Elkfork Partners’s GSK GSK Stock Holding History

Elkfork Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,259	Closed	-$515K	–	1033
2018 Q3	$515K	Hold	10,259	–	–	0.01%	585
2018 Q2	$517K	Hold	10,259	–	–	0.01%	522
2018 Q1	$501K	Hold	10,259	–	–	0.01%	523
2017 Q4	$455K	Hold	10,259	–	–	0.01%	564
2017 Q3	$521K	Hold	10,259	–	–	0.02%	476
2017 Q2	$553K	Hold	10,259	–	–	0.02%	469
2017 Q1	$541K	Hold	10,259	–	–	0.02%	435
2016 Q4	$494K	Buy	+10,259	New	+$507K	0.02%	414

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Elkfork Partners's GSK Position: Q4 2018 in Review

Elkfork Partners sold out of GSK (GSK) in Q4 2018, closing a stake of 10,259 shares — an estimated $515K sold.

Elkfork Partners first reported a position in GSK in Q4 2016 and held it in 8 quarters. The position peaked at $553K in Q2 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Elkfork Partners reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Elkfork Partners sold 10,259 GSK shares in Q4 2018, an estimated $515K.
Elkfork Partners first reported a position in GSK in Q4 2016 and held it in 8 quarters.
Elkfork Partners's GSK position peaked at $553K in Q2 2017.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Elkfork Partners's 13F filing for Q4 2018, filed 13 Feb 2019.